Fat loss
Cagrilintide
- 5mg*10vials USD 113.00
- 10mg*10vials USD 219.00
Reference price. The concierge confirms the amount before payment.
4.6 / 5 · 933 reviewsAfter the order is submitted, quote the order number when you write to the concierge.
Features
Long-acting satiety-inducing peptides; highly effective when used in combination with GLP-1.
Overview
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
Precautions
Reconstitution: Add 3.0 mL of bacteriostatic water → concentration ~1.67 mg/mL
Typical weekly dosage range: 0.6–4.5 mg once weekly (titrated gradually over 4–6 weeks)
Simple measurement: 1 unit = 0.01 mL ≈ 0.0167 mg (16.7 micrograms)
How to use
1. Draw 3.0 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid creating foam or vigorous agitation.
3. Gently swirl or roll the vial until the contents are completely dissolved (do not shake).
4. Label with the date and concentration; store refrigerated at 2–8°C, protected from light.
5. Use within 30 days of reconstitution; discard if the solution appears cloudy or contains particulate matter.
Storage
Lyophilized: Store at -20°C in a dry, dark place; minimize exposure to moisture.
After reconstitution: Store refrigerated at 2–8°C; use within 30 days, and avoid freeze-thaw cycles.
Reviews
4.6 / 5
933 reviews
Showing the latest 100 reviews.
-
★★★★★
VX2•••••••C805
United Kingdom
2026-10-23 13:08
The outer carton was solid. The batch note was readable. No issues on arrival.
-
★★★★★
VX5•••••••F3BC
Netherlands
2026-10-23 09:15
Tracking matched the arrival. The label matches the listing. No issues on arrival.
-
★★★★★
VXC•••••••81BE
Hong Kong
2026-10-23 05:22
Support confirmed the destination before dispatch. Nothing was missing. The experience was smooth.
-
★★★★★
VXE•••••••7189
Korea
2026-10-23 01:30
Support took a little while to reply. The item itself was fine. I can accept the slower shipping.
-
★★★★★
VX7•••••••21DB
Japan
2026-10-22 21:37
The box was plain and a little worn. The contents were complete. Support was accurate once they replied.
-
★★★★★
VX8•••••••1CCD
Japan
2026-10-22 17:44
Everything listed was in the box. The batch note was readable. The whole order was tidy.
-
★★★★★
VX2•••••••0B53
Germany
2026-10-22 13:52
The inner pack was tidy. Nothing was missing. Simple and correct.
-
★★★★★
VXE•••••••C6DE
Canada
2026-10-22 09:59
The delivery window was kept. The packing list was right. Clear from start to finish.
-
★★★★★
VX8•••••••FBDF
France
2026-10-22 06:06
The outer carton was solid. The contents were undamaged. A reliable delivery.
-
★★★★★
VXA•••••••78B7
Hong Kong
2026-10-22 02:14
The outer carton was solid. The cap was tight. A reliable delivery.
Buyer review
Enter the order number and the phone number from checkout. Both must match an order that includes this product.
Also listed
Fat loss
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
Reference priceUSD 116.00
Fat loss
Retatrutide
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
Reference priceUSD 45.00
Fat loss
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
Reference priceUSD 40.00
Fat loss
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
Reference priceUSD 41.00